ERBB4 and breast neoplasm: Nuclear HER4 intracellular domain (ICD) functions as a potent ER co-activator and promotes the proliferation of ER + breast tumor cells39 whereas cytosolic HER4 ICD has antiproliferative and pro-apoptotic activity including tamoxifen induced apoptosis40.